Profile data is unavailable for this security.
About the company
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its segments include Plasma, Blood Center and Hospital. Its Plasma segment offers automated plasma collection and donor management software systems that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to acquire blood, filter blood and separate blood components. Its Hospital segment provides the patient care. It markets and sells its products to biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations.
- Revenue in USD (TTM)933.83m
- Net income in USD31.24m
- Incorporated1985
- Employees2.71k
- LocationHaemonetics Corp125 SUMMER STREETBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outset Medical Inc | 91.70m | -122.75m | 1.81bn | 313.00 | -- | 4.40 | -- | 19.70 | -2.77 | -2.77 | 2.06 | 8.71 | 0.2005 | 3.77 | 6.95 | 292,961.70 | -26.83 | -- | -29.21 | -- | 5.13 | -- | -133.86 | -- | 9.64 | -90.75 | 0.0677 | -- | 231.18 | -- | 7.18 | -- | -- | -- |
| Fulgent Genetics Inc | 1.04bn | 569.33m | 1.81bn | 429.00 | 3.15 | 1.75 | 3.16 | 1.75 | 19.24 | 19.24 | 34.65 | 34.76 | 1.43 | -- | 9.72 | 2,414,664.00 | 77.82 | 33.25 | 91.17 | 38.12 | 80.19 | 74.66 | 54.54 | 39.63 | -- | -- | 0.0198 | 0.00 | 1,196.46 | 113.19 | 52,243.55 | -- | 75.67 | -- |
| Cytek Biosciences Inc | -100.00bn | -100.00bn | 1.90bn | 462.00 | -- | 4.72 | -- | -- | -- | -- | -- | 3.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.74 | -- | 0.00 | -- | 60.39 | -- | 119.11 | -- | -- | -- |
| Pacific Biosciences of California Inc | 121.63m | -36.96m | 2.22bn | 412.00 | -- | 2.64 | -- | 18.23 | -0.2459 | -0.2459 | 0.5835 | 3.81 | 0.1042 | 3.98 | 6.80 | 295,218.40 | -3.17 | -37.11 | -3.44 | -46.53 | 43.98 | 39.54 | -30.39 | -74.86 | 19.99 | -15.36 | 0.5159 | -- | -13.20 | -3.19 | 134.95 | -- | -19.16 | -- |
| Axonics Inc | 161.94m | -76.25m | 2.28bn | 416.00 | -- | 4.66 | -- | 14.10 | -1.83 | -1.83 | 3.90 | 10.59 | 0.3563 | 1.04 | 7.31 | 389,274.00 | -16.78 | -- | -18.10 | -- | 63.27 | -- | -47.09 | -- | 9.36 | -8.10 | 0.0002 | -- | 707.06 | -- | 31.30 | -- | -- | -- |
| Glaukos Corp | 294.01m | -38.37m | 2.41bn | 653.00 | -- | 4.01 | -- | 8.19 | -0.8477 | -0.8477 | 6.31 | 12.83 | 0.2856 | 3.50 | 8.63 | 450,237.40 | -3.73 | -6.01 | -3.94 | -6.60 | 76.41 | 78.99 | -13.05 | -12.37 | 7.60 | -3.74 | 0.3697 | -- | -5.07 | 25.69 | -880.26 | -- | -15.27 | -- |
| Adapthealth Corp | 2.12bn | -42.36m | 2.43bn | 8.70k | -- | 1.22 | 17.07 | 1.15 | -1.60 | -1.60 | 18.07 | 15.06 | 0.6276 | 22.83 | 8.55 | 243,119.00 | -1.87 | -- | -2.13 | -- | 21.01 | -- | -2.98 | -- | 1.44 | 1.58 | 0.5278 | -- | 102.15 | -- | -657.38 | -- | -- | -- |
| Haemonetics Corporation | 933.83m | 31.24m | 2.51bn | 2.71k | 81.11 | 3.59 | 20.47 | 2.68 | 0.6049 | 0.6049 | 18.26 | 13.68 | 0.5801 | 1.59 | 6.60 | 344,839.40 | 1.94 | 3.92 | 2.41 | 4.91 | 46.61 | 46.02 | 3.35 | 5.59 | 1.31 | 5.84 | 0.5278 | 0.00 | -11.94 | -0.859 | 3.85 | -- | -18.40 | -- |
| Integer Holdings Corp | 1.18bn | 88.45m | 2.63bn | 7.50k | 29.97 | 1.98 | 15.56 | 2.24 | 2.66 | 2.66 | 35.43 | 40.35 | 0.4907 | 5.55 | 5.50 | 156,936.40 | 3.69 | 2.29 | 3.94 | 2.47 | 27.89 | 29.44 | 7.51 | 5.19 | 1.88 | 4.54 | 0.3213 | 0.00 | -14.68 | 6.05 | -15.30 | -- | 2.89 | -- |
| Patterson Companies, Inc. | 6.38bn | 159.84m | 2.71bn | 7.80k | 16.98 | 2.68 | 11.29 | 0.4244 | 1.64 | 1.64 | 65.22 | 10.37 | 2.24 | 6.40 | 13.10 | 817,576.70 | 5.58 | -0.3475 | 9.28 | -0.492 | 20.11 | 21.73 | 2.49 | -0.1996 | 0.8125 | -- | 0.3844 | -- | 7.69 | 1.88 | 126.51 | -3.43 | -20.13 | 2.93 |
| AtriCure Inc. | 258.84m | 45.38m | 2.82bn | 750.00 | 66.36 | 5.78 | 51.18 | 10.90 | 0.9259 | 0.9259 | 5.82 | 10.63 | 0.392 | 1.80 | 8.78 | 345,114.70 | 6.87 | -8.44 | 7.43 | -9.35 | 74.67 | 72.67 | 17.53 | -17.00 | 2.91 | 30.38 | 0.1215 | -- | -10.52 | 9.74 | -36.83 | -- | -17.12 | -- |
| NuVasive, Inc. | 1.13bn | -25.66m | 2.99bn | 2.70k | -- | 3.62 | 24.71 | 2.65 | -0.4976 | -0.4976 | 21.85 | 15.95 | 0.4712 | 1.05 | 5.58 | 418,044.40 | -1.07 | 1.55 | -1.36 | 1.81 | 71.35 | 72.62 | -2.27 | 2.57 | 2.35 | 1.77 | 0.5176 | 0.00 | -10.06 | 5.31 | -156.95 | -- | 0.3312 | -- |
| Nevro Corp | 393.88m | -108.36m | 3.00bn | 843.00 | -- | 9.39 | -- | 7.61 | -3.12 | -3.12 | 11.35 | 9.15 | 0.5789 | 1.35 | 5.54 | 467,231.30 | -15.92 | -12.91 | -20.71 | -15.32 | 69.80 | 69.17 | -27.51 | -17.96 | 5.97 | -2.92 | 0.318 | -- | -7.23 | 39.07 | 19.89 | -- | 3.77 | -- |
| Agape ATP Corp | 1.32m | -1.46m | 3.01bn | 35.00 | -- | 703.15 | -- | 2,277.13 | -0.0039 | -0.0039 | 0.0035 | 0.0114 | 0.2153 | 0.5409 | 9.56 | 37,787.14 | -23.82 | -- | -28.05 | -- | 79.79 | -- | -110.61 | -- | 4.27 | -49.54 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Merit Medical Systems, Inc. | 1.05bn | 43.22m | 3.14bn | 5.99k | 73.02 | 3.10 | 24.19 | 2.98 | 0.7628 | 0.7628 | 18.55 | 17.95 | 0.6363 | 2.81 | 7.20 | 176,033.20 | 2.61 | 1.36 | 2.97 | 1.52 | 44.36 | 43.60 | 4.10 | 2.17 | 1.20 | 13.45 | 0.2157 | 0.00 | -3.11 | 12.20 | -280.57 | -- | -1.41 | -- |
| Inmode Ltd | 322.21m | 148.40m | 3.29bn | 311.00 | 24.83 | 8.55 | 22.06 | 10.20 | 1.73 | 1.73 | 3.76 | 5.03 | 0.8928 | 2.78 | 16.61 | 1,036,051.00 | 41.14 | -- | 47.10 | -- | 85.31 | -- | 46.07 | -- | 7.81 | -- | 0.00 | -- | 31.81 | -- | 22.71 | -- | -- | -- |
Data as of Jan 21 2022. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD
51.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2021 | 5.57m | 10.90% |
| The Vanguard Group, Inc.as of 30 Sep 2021 | 4.76m | 9.31% |
| Wellington Management Co. LLPas of 30 Sep 2021 | 4.24m | 8.31% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2021 | 3.86m | 7.55% |
| SSgA Funds Management, Inc.as of 30 Sep 2021 | 1.66m | 3.25% |
| Franklin Advisers, Inc.as of 30 Sep 2021 | 1.47m | 2.88% |
| Westfield Capital Management Co. LPas of 30 Sep 2021 | 1.36m | 2.66% |
| LGT Capital Partners AG (Investment Management)as of 31 Dec 2021 | 1.22m | 2.38% |
| Janus Capital Management LLCas of 30 Sep 2021 | 1.20m | 2.36% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2021 | 1.13m | 2.22% |
More ▼
Data from 30 Sep 2021 - 31 Dec 2021Source: FactSet Research Systems Inc.
